Cepheid Stock

Stocks

01/05/12

16/02/17	Cepheid : Announces FDA Clearance Of Xpert® Xpress Flu And Xpert Xpress Flu/RSV	PU
05/11/16	Cepheid : Danaher Completes Acquisition Of Cepheid	PR
27/10/16	Cepheid : 30 Minute Or Less Molecular Flu/RSV Test Now Available Outside The US	PR
24/10/16	Cepheid : Announces Receipt of Required Regulatory Clearances in Proposed Acquisition by Danaher Corporation	PR
06/10/16	Cepheid : New Bladder Cancer Test Could Reduce Number Of Invasive Procedures Required For Recurrence Monitoring	PR

06/09/16	Danaher : renforce dans les diagnostics avec Cepheid
06/09/16	Danaher : acquiert le spécialiste des diagnostics Cepheid

Manager	Title	Age	Since
Charles Mwangi DFI	Director of Finance/CFO	59	01/07/2023
Anupama Mokkapati COO	Chief Operating Officer	-	01/11/2021
Laurent Bellon COO	Chief Operating Officer	-	01/08/2018

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CEPHEID	-.--%	+0.36%	-	-	0
SARTORIUS AG	+0.87%	-1.81%	+20.30%	-31.05%	16.65B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	-1.77%	+7.05%	-31.49%	+58.12%	1.78B
ECKERT & ZIEGLER SE	+0.08%	-4.28%	-28.11%	+22.84%	894M
QUIDELORTHO CORPORATION	-0.91%	-14.24%	-59.99%	-83.92%	833M
VAREX IMAGING CORPORATION	-0.03%	-0.24%	+60.57%	-3.12%	778M
CONTEC MEDICAL SYSTEMS CO.,LTD	-2.56%	-5.08%	-37.23%	-49.60%	654M
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-5.26%	-9.30%	-44.97%	-48.89%	591M
REVENIO GROUP OYJ	+3.41%	-14.92%	-43.23%	-39.69%	436M
908 DEVICES INC.	+3.48%	-3.58%	+69.41%	+49.77%	386M
Average	-0.30%	-6.09%	-10.53%	-13.95%	2.56B
Weighted average by Cap.	+0.35%	-4.95%	+9.17%	-22.81%